Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 -268.58M
December 31, 2024 -500.95M
December 31, 2023 -307.51M
December 31, 2022 -274.37M
December 31, 2021 30.80M
December 31, 2020 35.89M
December 31, 2019 345.72M
December 31, 2018 602.89M
December 31, 2017 174.15M
December 31, 2016 -112.10M
December 31, 2015 21.12M
December 31, 2014 6.285M
December 31, 2013 63.49M
December 31, 2012 1.876M
December 31, 2011 -114.80M
December 31, 2010 -63.59M
December 31, 2009 -108.44M
December 31, 2008 212.03M
Date Value
December 31, 2007 36.09M
December 31, 2006 -53.22M
December 31, 2005 -61.74M
December 31, 2004 -101.75M
December 31, 2003 -95.47M
December 31, 2002 -94.38M
December 31, 2001 -6.158M
December 31, 2000 -23.19M
December 31, 1999 -48.36M
December 31, 1998 -34.72M
December 31, 1997 -20.55M
December 31, 1996 -21.15M
December 31, 1995 -15.08M
December 31, 1994 -15.23M
December 31, 1993 -15.30M
December 31, 1992 -19.37M
December 31, 1991 -1.489M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 524.08M
Biogen, Inc. 2.205B
BridgeBio Pharma, Inc. -445.91M
Vertex Pharmaceuticals, Inc. 3.631B
Arrowhead Pharmaceuticals, Inc. 179.55M